img

Global Mono Hepatitis A Vaccine Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Mono Hepatitis A Vaccine Market Insights, Forecast to 2034

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Global Mono Hepatitis A Vaccine market is expected to reach to US$ 751.6 million in 2024, with a positive growth of %, compared with US$ 735.9 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Mono Hepatitis A Vaccine industry is evaluated to reach US$ 858.4 million in 2029. The CAGR will be 2.2% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Mono Hepatitis A Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Mono Hepatitis A Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
AIM Vaccine
Segment by Type
Inactivated Vaccine
Live Attenuated Vaccine

Segment by Application


Government Institution
Private Sector
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Mono Hepatitis A Vaccine plant distribution, commercial date of Mono Hepatitis A Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Mono Hepatitis A Vaccine introduction, etc. Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Mono Hepatitis A Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Mono Hepatitis A Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Mono Hepatitis A Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Market by Application
1.3.1 Global Mono Hepatitis A Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Mono Hepatitis A Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Mono Hepatitis A Vaccine Revenue by Region
2.2.1 Global Mono Hepatitis A Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Mono Hepatitis A Vaccine Revenue by Region (2018-2024)
2.2.3 Global Mono Hepatitis A Vaccine Revenue by Region (2024-2029)
2.2.4 Global Mono Hepatitis A Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Mono Hepatitis A Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Mono Hepatitis A Vaccine Sales by Region
2.4.1 Global Mono Hepatitis A Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Mono Hepatitis A Vaccine Sales by Region (2018-2024)
2.4.3 Global Mono Hepatitis A Vaccine Sales by Region (2024-2029)
2.4.4 Global Mono Hepatitis A Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Mono Hepatitis A Vaccine Sales by Manufacturers
3.1.1 Global Mono Hepatitis A Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Mono Hepatitis A Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Mono Hepatitis A Vaccine in 2022
3.2 Global Mono Hepatitis A Vaccine Revenue by Manufacturers
3.2.1 Global Mono Hepatitis A Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Mono Hepatitis A Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Mono Hepatitis A Vaccine Revenue in 2022
3.3 Global Key Players of Mono Hepatitis A Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Mono Hepatitis A Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Mono Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Mono Hepatitis A Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Mono Hepatitis A Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Mono Hepatitis A Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Mono Hepatitis A Vaccine Sales by Type
4.1.1 Global Mono Hepatitis A Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Mono Hepatitis A Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Mono Hepatitis A Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Mono Hepatitis A Vaccine Revenue by Type
4.2.1 Global Mono Hepatitis A Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Mono Hepatitis A Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Mono Hepatitis A Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Mono Hepatitis A Vaccine Price by Type
4.3.1 Global Mono Hepatitis A Vaccine Price by Type (2018-2024)
4.3.2 Global Mono Hepatitis A Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Mono Hepatitis A Vaccine Sales by Application
5.1.1 Global Mono Hepatitis A Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Mono Hepatitis A Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Mono Hepatitis A Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Mono Hepatitis A Vaccine Revenue by Application
5.2.1 Global Mono Hepatitis A Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Mono Hepatitis A Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Mono Hepatitis A Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Mono Hepatitis A Vaccine Price by Application
5.3.1 Global Mono Hepatitis A Vaccine Price by Application (2018-2024)
5.3.2 Global Mono Hepatitis A Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Mono Hepatitis A Vaccine Market Size by Type
6.1.1 US & Canada Mono Hepatitis A Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Mono Hepatitis A Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Mono Hepatitis A Vaccine Market Size by Application
6.2.1 US & Canada Mono Hepatitis A Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Mono Hepatitis A Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Mono Hepatitis A Vaccine Market Size by Country
6.3.1 US & Canada Mono Hepatitis A Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Mono Hepatitis A Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Mono Hepatitis A Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Mono Hepatitis A Vaccine Market Size by Type
7.1.1 Europe Mono Hepatitis A Vaccine Sales by Type (2018-2029)
7.1.2 Europe Mono Hepatitis A Vaccine Revenue by Type (2018-2029)
7.2 Europe Mono Hepatitis A Vaccine Market Size by Application
7.2.1 Europe Mono Hepatitis A Vaccine Sales by Application (2018-2029)
7.2.2 Europe Mono Hepatitis A Vaccine Revenue by Application (2018-2029)
7.3 Europe Mono Hepatitis A Vaccine Market Size by Country
7.3.1 Europe Mono Hepatitis A Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Mono Hepatitis A Vaccine Sales by Country (2018-2029)
7.3.3 Europe Mono Hepatitis A Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Mono Hepatitis A Vaccine Market Size
8.1.1 China Mono Hepatitis A Vaccine Sales (2018-2029)
8.1.2 China Mono Hepatitis A Vaccine Revenue (2018-2029)
8.2 China Mono Hepatitis A Vaccine Market Size by Application
8.2.1 China Mono Hepatitis A Vaccine Sales by Application (2018-2029)
8.2.2 China Mono Hepatitis A Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Mono Hepatitis A Vaccine Market Size by Type
9.1.1 Asia Mono Hepatitis A Vaccine Sales by Type (2018-2029)
9.1.2 Asia Mono Hepatitis A Vaccine Revenue by Type (2018-2029)
9.2 Asia Mono Hepatitis A Vaccine Market Size by Application
9.2.1 Asia Mono Hepatitis A Vaccine Sales by Application (2018-2029)
9.2.2 Asia Mono Hepatitis A Vaccine Revenue by Application (2018-2029)
9.3 Asia Mono Hepatitis A Vaccine Sales by Region
9.3.1 Asia Mono Hepatitis A Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Mono Hepatitis A Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Mono Hepatitis A Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Mono Hepatitis A Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Mono Hepatitis A Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Mono Hepatitis A Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Mono Hepatitis A Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Mono Hepatitis A Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Mono Hepatitis A Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Mono Hepatitis A Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Mono Hepatitis A Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Mono Hepatitis A Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Mono Hepatitis A Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Overview
11.1.3 GSK Mono Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 GSK Mono Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Overview
11.2.3 Merck Mono Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Merck Mono Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Mono Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Sanofi Mono Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Sinovac
11.4.1 Sinovac Company Information
11.4.2 Sinovac Overview
11.4.3 Sinovac Mono Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Sinovac Mono Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sinovac Recent Developments
11.5 Zhejiang Pukang
11.5.1 Zhejiang Pukang Company Information
11.5.2 Zhejiang Pukang Overview
11.5.3 Zhejiang Pukang Mono Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Zhejiang Pukang Mono Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Zhejiang Pukang Recent Developments
11.6 Changchun Institute of Biological
11.6.1 Changchun Institute of Biological Company Information
11.6.2 Changchun Institute of Biological Overview
11.6.3 Changchun Institute of Biological Mono Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Changchun Institute of Biological Mono Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Changchun Institute of Biological Recent Developments
11.7 KM Biologics
11.7.1 KM Biologics Company Information
11.7.2 KM Biologics Overview
11.7.3 KM Biologics Mono Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 KM Biologics Mono Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 KM Biologics Recent Developments
11.8 IMBCAMS
11.8.1 IMBCAMS Company Information
11.8.2 IMBCAMS Overview
11.8.3 IMBCAMS Mono Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 IMBCAMS Mono Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 IMBCAMS Recent Developments
11.9 AIM Vaccine
11.9.1 AIM Vaccine Company Information
11.9.2 AIM Vaccine Overview
11.9.3 AIM Vaccine Mono Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 AIM Vaccine Mono Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 AIM Vaccine Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Mono Hepatitis A Vaccine Industry Chain Analysis
12.2 Mono Hepatitis A Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Mono Hepatitis A Vaccine Production Mode & Process
12.4 Mono Hepatitis A Vaccine Sales and Marketing
12.4.1 Mono Hepatitis A Vaccine Sales Channels
12.4.2 Mono Hepatitis A Vaccine Distributors
12.5 Mono Hepatitis A Vaccine Customers
13 Market Dynamics
13.1 Mono Hepatitis A Vaccine Industry Trends
13.2 Mono Hepatitis A Vaccine Market Drivers
13.3 Mono Hepatitis A Vaccine Market Challenges
13.4 Mono Hepatitis A Vaccine Market Restraints
14 Key Findings in The Global Mono Hepatitis A Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Mono Hepatitis A Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Inactivated Vaccine
Table 3. Major Manufacturers of Live Attenuated Vaccine
Table 4. Global Mono Hepatitis A Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Mono Hepatitis A Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Mono Hepatitis A Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Mono Hepatitis A Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Mono Hepatitis A Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Mono Hepatitis A Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Mono Hepatitis A Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Mono Hepatitis A Vaccine Sales by Region (2018-2024) & (K Units)
Table 12. Global Mono Hepatitis A Vaccine Sales by Region (2024-2029) & (K Units)
Table 13. Global Mono Hepatitis A Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Mono Hepatitis A Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Mono Hepatitis A Vaccine Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Mono Hepatitis A Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Mono Hepatitis A Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Mono Hepatitis A Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Mono Hepatitis A Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Mono Hepatitis A Vaccine Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Mono Hepatitis A Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Mono Hepatitis A Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mono Hepatitis A Vaccine as of 2022)
Table 23. Global Key Manufacturers of Mono Hepatitis A Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Mono Hepatitis A Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Mono Hepatitis A Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Mono Hepatitis A Vaccine Sales by Type (2018-2024) & (K Units)
Table 28. Global Mono Hepatitis A Vaccine Sales by Type (2024-2029) & (K Units)
Table 29. Global Mono Hepatitis A Vaccine Sales Share by Type (2018-2024)
Table 30. Global Mono Hepatitis A Vaccine Sales Share by Type (2024-2029)
Table 31. Global Mono Hepatitis A Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Mono Hepatitis A Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Mono Hepatitis A Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Mono Hepatitis A Vaccine Revenue Share by Type (2024-2029)
Table 35. Mono Hepatitis A Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Mono Hepatitis A Vaccine Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Mono Hepatitis A Vaccine Sales by Application (2018-2024) & (K Units)
Table 38. Global Mono Hepatitis A Vaccine Sales by Application (2024-2029) & (K Units)
Table 39. Global Mono Hepatitis A Vaccine Sales Share by Application (2018-2024)
Table 40. Global Mono Hepatitis A Vaccine Sales Share by Application (2024-2029)
Table 41. Global Mono Hepatitis A Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Mono Hepatitis A Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Mono Hepatitis A Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Mono Hepatitis A Vaccine Revenue Share by Application (2024-2029)
Table 45. Mono Hepatitis A Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Mono Hepatitis A Vaccine Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Mono Hepatitis A Vaccine Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Mono Hepatitis A Vaccine Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Mono Hepatitis A Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Mono Hepatitis A Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Mono Hepatitis A Vaccine Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Mono Hepatitis A Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Mono Hepatitis A Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Mono Hepatitis A Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Mono Hepatitis A Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Mono Hepatitis A Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Mono Hepatitis A Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Mono Hepatitis A Vaccine Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Mono Hepatitis A Vaccine Sales by Country (2024-2029) & (K Units)
Table 60. Europe Mono Hepatitis A Vaccine Sales by Type (2018-2024) & (K Units)
Table 61. Europe Mono Hepatitis A Vaccine Sales by Type (2024-2029) & (K Units)
Table 62. Europe Mono Hepatitis A Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Mono Hepatitis A Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Mono Hepatitis A Vaccine Sales by Application (2018-2024) & (K Units)
Table 65. Europe Mono Hepatitis A Vaccine Sales by Application (2024-2029) & (K Units)
Table 66. Europe Mono Hepatitis A Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Mono Hepatitis A Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Mono Hepatitis A Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Mono Hepatitis A Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Mono Hepatitis A Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Mono Hepatitis A Vaccine Sales by Country (2018-2024) & (K Units)
Table 72. Europe Mono Hepatitis A Vaccine Sales by Country (2024-2029) & (K Units)
Table 73. China Mono Hepatitis A Vaccine Sales by Type (2018-2024) & (K Units)
Table 74. China Mono Hepatitis A Vaccine Sales by Type (2024-2029) & (K Units)
Table 75. China Mono Hepatitis A Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Mono Hepatitis A Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Mono Hepatitis A Vaccine Sales by Application (2018-2024) & (K Units)
Table 78. China Mono Hepatitis A Vaccine Sales by Application (2024-2029) & (K Units)
Table 79. China Mono Hepatitis A Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Mono Hepatitis A Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Mono Hepatitis A Vaccine Sales by Type (2018-2024) & (K Units)
Table 82. Asia Mono Hepatitis A Vaccine Sales by Type (2024-2029) & (K Units)
Table 83. Asia Mono Hepatitis A Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Mono Hepatitis A Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Mono Hepatitis A Vaccine Sales by Application (2018-2024) & (K Units)
Table 86. Asia Mono Hepatitis A Vaccine Sales by Application (2024-2029) & (K Units)
Table 87. Asia Mono Hepatitis A Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Mono Hepatitis A Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Mono Hepatitis A Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Mono Hepatitis A Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Mono Hepatitis A Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Mono Hepatitis A Vaccine Sales by Region (2018-2024) & (K Units)
Table 93. Asia Mono Hepatitis A Vaccine Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Sales by Country (2024-2029) & (K Units)
Table 107. GSK Company Information
Table 108. GSK Description and Major Businesses
Table 109. GSK Mono Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. GSK Mono Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. GSK Recent Developments
Table 112. Merck Company Information
Table 113. Merck Description and Major Businesses
Table 114. Merck Mono Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Merck Mono Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Merck Recent Developments
Table 117. Sanofi Company Information
Table 118. Sanofi Description and Major Businesses
Table 119. Sanofi Mono Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Sanofi Mono Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sanofi Recent Developments
Table 122. Sinovac Company Information
Table 123. Sinovac Description and Major Businesses
Table 124. Sinovac Mono Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Sinovac Mono Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Sinovac Recent Developments
Table 127. Zhejiang Pukang Company Information
Table 128. Zhejiang Pukang Description and Major Businesses
Table 129. Zhejiang Pukang Mono Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Zhejiang Pukang Mono Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Zhejiang Pukang Recent Developments
Table 132. Changchun Institute of Biological Company Information
Table 133. Changchun Institute of Biological Description and Major Businesses
Table 134. Changchun Institute of Biological Mono Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Changchun Institute of Biological Mono Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Changchun Institute of Biological Recent Developments
Table 137. KM Biologics Company Information
Table 138. KM Biologics Description and Major Businesses
Table 139. KM Biologics Mono Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. KM Biologics Mono Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. KM Biologics Recent Developments
Table 142. IMBCAMS Company Information
Table 143. IMBCAMS Description and Major Businesses
Table 144. IMBCAMS Mono Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. IMBCAMS Mono Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. IMBCAMS Recent Developments
Table 147. AIM Vaccine Company Information
Table 148. AIM Vaccine Description and Major Businesses
Table 149. AIM Vaccine Mono Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. AIM Vaccine Mono Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. AIM Vaccine Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Mono Hepatitis A Vaccine Distributors List
Table 155. Mono Hepatitis A Vaccine Customers List
Table 156. Mono Hepatitis A Vaccine Market Trends
Table 157. Mono Hepatitis A Vaccine Market Drivers
Table 158. Mono Hepatitis A Vaccine Market Challenges
Table 159. Mono Hepatitis A Vaccine Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Mono Hepatitis A Vaccine Product Picture
Figure 2. Global Mono Hepatitis A Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Mono Hepatitis A Vaccine Market Share by Type in 2022 & 2029
Figure 4. Inactivated Vaccine Product Picture
Figure 5. Live Attenuated Vaccine Product Picture
Figure 6. Global Mono Hepatitis A Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Mono Hepatitis A Vaccine Market Share by Application in 2022 & 2029
Figure 8. Government Institution
Figure 9. Private Sector
Figure 10. Other
Figure 11. Mono Hepatitis A Vaccine Report Years Considered
Figure 12. Global Mono Hepatitis A Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Mono Hepatitis A Vaccine Revenue 2018-2029 (US$ Million)
Figure 14. Global Mono Hepatitis A Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Mono Hepatitis A Vaccine Revenue Market Share by Region (2018-2029)
Figure 16. Global Mono Hepatitis A Vaccine Sales 2018-2029 ((K Units)
Figure 17. Global Mono Hepatitis A Vaccine Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Mono Hepatitis A Vaccine Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Mono Hepatitis A Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Mono Hepatitis A Vaccine Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Mono Hepatitis A Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Mono Hepatitis A Vaccine Sales YoY (2018-2029) & (K Units)
Figure 23. China Mono Hepatitis A Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Mono Hepatitis A Vaccine Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Mono Hepatitis A Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Mono Hepatitis A Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Mono Hepatitis A Vaccine in the World: Market Share by Mono Hepatitis A Vaccine Revenue in 2022
Figure 30. Global Mono Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Mono Hepatitis A Vaccine Sales Market Share by Type (2018-2029)
Figure 32. Global Mono Hepatitis A Vaccine Revenue Market Share by Type (2018-2029)
Figure 33. Global Mono Hepatitis A Vaccine Sales Market Share by Application (2018-2029)
Figure 34. Global Mono Hepatitis A Vaccine Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Mono Hepatitis A Vaccine Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Mono Hepatitis A Vaccine Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Mono Hepatitis A Vaccine Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Mono Hepatitis A Vaccine Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Mono Hepatitis A Vaccine Revenue Share by Country (2018-2029)
Figure 40. US & Canada Mono Hepatitis A Vaccine Sales Share by Country (2018-2029)
Figure 41. U.S. Mono Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Mono Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Mono Hepatitis A Vaccine Sales Market Share by Type (2018-2029)
Figure 44. Europe Mono Hepatitis A Vaccine Revenue Market Share by Type (2018-2029)
Figure 45. Europe Mono Hepatitis A Vaccine Sales Market Share by Application (2018-2029)
Figure 46. Europe Mono Hepatitis A Vaccine Revenue Market Share by Application (2018-2029)
Figure 47. Europe Mono Hepatitis A Vaccine Revenue Share by Country (2018-2029)
Figure 48. Europe Mono Hepatitis A Vaccine Sales Share by Country (2018-2029)
Figure 49. Germany Mono Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. France Mono Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Mono Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Mono Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Mono Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 54. China Mono Hepatitis A Vaccine Sales Market Share by Type (2018-2029)
Figure 55. China Mono Hepatitis A Vaccine Revenue Market Share by Type (2018-2029)
Figure 56. China Mono Hepatitis A Vaccine Sales Market Share by Application (2018-2029)
Figure 57. China Mono Hepatitis A Vaccine Revenue Market Share by Application (2018-2029)
Figure 58. Asia Mono Hepatitis A Vaccine Sales Market Share by Type (2018-2029)
Figure 59. Asia Mono Hepatitis A Vaccine Revenue Market Share by Type (2018-2029)
Figure 60. Asia Mono Hepatitis A Vaccine Sales Market Share by Application (2018-2029)
Figure 61. Asia Mono Hepatitis A Vaccine Revenue Market Share by Application (2018-2029)
Figure 62. Asia Mono Hepatitis A Vaccine Revenue Share by Region (2018-2029)
Figure 63. Asia Mono Hepatitis A Vaccine Sales Share by Region (2018-2029)
Figure 64. Japan Mono Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Mono Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Mono Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Mono Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. India Mono Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Mono Hepatitis A Vaccine Sales Share by Country (2018-2029)
Figure 75. Brazil Mono Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Mono Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Mono Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Mono Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Mono Hepatitis A Vaccine Revenue (2018-2029) & (US$ Million)
Figure 80. Mono Hepatitis A Vaccine Value Chain
Figure 81. Mono Hepatitis A Vaccine Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed